Workshops

​​EAS Banner.jpg​​​​​

VASCULAR BIOLOGY OF THE ARTERIAL WALL

Metabolism and functions of lipids in vascular cells

  • Cellular lipid trafficking - Elina Ikonen, Finland
  • Sphingosine-1-phosphate – Roch Nofer, Germany

Immunology of atherosclerosis

Atherosclerosis regression

  • Metalloproteinases - Andrew Newby, UK 
  • Macrophage trafficking - Gwendalyn Randolph,USA

​Endothelial cell biology and angiogenesis

  • Angiogenesis – Michael Detmar, Switzerland 
  • Regulation of endothelial barrier integrity – Asrar B.Malik, USA  

LIPID AND LIPOPROTEIN METABOLISM 

Genomics and proteomics of lipid metabolism

  • Genomics (GWAS) - Marcello Arca, Italy   
  • Structure-function relationships across HDL particles as revealed by proteomics and lipidomics​​​​ – Anatol Kontush, France​

​New protective effects of HDL on the cardiovascular system and beyond

​Role of the intestine for lipid homeostasis and atherosclerosis

  • Intestinal transporters, TICE – Bert Groen, The Netherlands  
  • Choline and carnitine metabolism – Max Nieuwdorp, The Netherlands

​Adipose tissue biology

  • Abdominal fat   - Peter Arner, Sweden
  • Brown adipose tissue - Jörg  Heeren, Germany 

RISK FACTORS, EPIDEMIOLOGY, PREVENTION, AND TREATMENT OF CARDIOVASCULAR DISEASE 

Hypolidaemic drugs present and future

  • State of the art in lipid lowering therapy  -  Rafael Carmena , Spain
  • Future developments of lipid lowering drugs  -  Alberto Corsini, Italy  

Nutrition and nutraceuticals

  • Nutrigenomics and functional food –  Helena Gylling, Finland 
  • Mediterranean diet  - Emilio Ros,​ Spain

Gene-environment interactions and Epigenetics

Environmental and psychosocial stressors in cardiovascular disease

  • Stress, socioeconomic status and cardiovascular disease risk: An update on current knowledge ​ - Mika Kivimäki , UK 
  • Environmental and behavioural risk factors - Fernando Rodríguez-Artalejo, Spain 

ADVANCED CLINICAL SEMINARS

Imaging of atherosclerosis and cardiovascular disease

  •  Epidemiological and clini​cial evidence in favour or against clinical utility of different procedures   -      ​Dan O'Leary, USA
  •  Novel methods - Erik Stroes , The Netherlands​​

Optimizing treatment of familial hypercholesterolemia

​New Targets for lipid lowering therapy

​Ectopic fat as a cardiovascular risk 

 

(Please note that presentation titles are subject to change)




Keep Me Updated